Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Court Rules Enanta Patent Invalid in Pfizer Paxlovid Case; Appeal Planned
FDA Approves First Generic of Novo Nordisk's Victoza
Schwab US Dividend Equity ETF Reverses In December: What's Going On?